In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Teladoc Health Inc (NYSE: TDOC) closed the day trading at $8.19 up 3.02% from the previous closing price of $7.95. In other words, the price has increased by $3.02 from its previous closing price. On the day, 5.36 million shares were traded. TDOC stock price reached its highest trading level at $8.24 during the session, while it also had its lowest trading level at $7.78.
Ratios:
For a better understanding of TDOC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.13 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.96. For the most recent quarter (mrq), Quick Ratio is recorded 2.49 and its Current Ratio is at 2.59. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Mizuho on July 25, 2025, initiated with a Neutral rating and assigned the stock a target price of $10.
On November 15, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $14. Jefferies reiterated its Hold rating for the stock on September 17, 2024, while the target price for the stock was revised from $8 to $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’25 when DIVITA CHARLES III sold 16,787 shares for $7.59 per share. The transaction valued at 127,435 led to the insider holds 179,014 shares of the business.
DIVITA CHARLES III bought 16,787 shares of TDOC for $127,435 on Sep 11 ’25. On Sep 03 ’25, another insider, Rodrigues Fernando M., who serves as the President of BetterHelp of the company, sold 4,149 shares for $7.59 each. As a result, the insider received 31,491 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TDOC now has a Market Capitalization of 1447096448 and an Enterprise Value of 1802567552. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.57 while its Price-to-Book (P/B) ratio in mrq is 1.02. Its current Enterprise Value per Revenue stands at 0.709 whereas that against EBITDA is 95.465.
Stock Price History:
The Beta on a monthly basis for TDOC is 1.92, which has changed by -0.0714286 over the last 52 weeks, in comparison to a change of 0.1675967 over the same period for the S&P500. Over the past 52 weeks, TDOC has reached a high of $15.21, while it has fallen to a 52-week low of $6.35. The 50-Day Moving Average of the stock is 6.94%, while the 200-Day Moving Average is calculated to be -4.08%.
Shares Statistics:
Over the past 3-months, TDOC traded about 7.06M shares per day on average, while over the past 10 days, TDOC traded about 4396690 shares per day. A total of 176.61M shares are outstanding, with a floating share count of 174.69M. Insiders hold about 1.13% of the company’s shares, while institutions hold 73.77% stake in the company. Shares short for TDOC as of 1756425600 were 23023535 with a Short Ratio of 3.26, compared to 1753920000 on 24009369. Therefore, it implies a Short% of Shares Outstanding of 23023535 and a Short% of Float of 14.57.
Earnings Estimates
The current assessment of Teladoc Health Inc (TDOC) involves the perspectives of 3.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.24 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.84 and -$1.35 for the fiscal current year, implying an average EPS of -$1.21. EPS for the following year is -$0.96, with 4.0 analysts recommending between -$0.93 and -$0.99.
Revenue Estimates
23 analysts predict $625.66M in revenue for the current quarter. It ranges from a high estimate of $629.95M to a low estimate of $619.6M. As of the current estimate, Teladoc Health Inc’s year-ago sales were $640.51MFor the next quarter, 23 analysts are estimating revenue of $634.31M. There is a high estimate of $642.65M for the next quarter, whereas the lowest estimate is $621.4M.
A total of 24 analysts have provided revenue estimates for TDOC’s current fiscal year. The highest revenue estimate was $2.53B, while the lowest revenue estimate was $2.5B, resulting in an average revenue estimate of $2.52B. In the same quarter a year ago, actual revenue was $2.57BBased on 24 analysts’ estimates, the company’s revenue will be $2.55B in the next fiscal year. The high estimate is $2.62B and the low estimate is $2.49B.
